Citations

Institution: Mayo Clinic Clear

Showing 10 of 108094 citations.

Lower Trapezius Tendon Transfer Using Achilles Tendon Allograft Effectively Restores Function After Failed Superior Capsular Reconstruction
Marigi, Erick M. , Baek, Chang Hee , Lim, Chaemoon , Baek, Gyuna , Elhassan, Bassem T. , Marigi, Erick , Kim, Bo Taek , Kim, Jung-Gon

Arthroscopy, Sports Medicine, and Rehabilitation | July 22, 2025 | Volume: 7 | Issue: 5 | Pages: No page available

10.1016/j.asmr.2025.101222 | PMID 41583800 Get It

Purpose To evaluate the clinical outcomes of lower trapezius tendon (LTT) transfer using an Achilles tendon allograft in patients with failed superior capsular reconstruction (SCR). Methods A retrospective therapeutic review was conducted on patients who underwent LTT transfer using an Achilles tendon allograft after SCR failure between January 2018 and May 2020. The inclusion criteria encompassed both structural and functional failures of SCR in patients with minimal glenohumeral arthritis and a minimum follow‐up of 2 years. Exclusion criteria were insufficient clinical data or loss to follow‐up. Clinical outcomes were assessed preoperatively and at final follow‐up using the visual analog scale (VAS), subjective shoulder value (SSV), Constant score, American Shoulder and Elbow Surgeons (ASES) score, and range of motion (ROM). Results Eighteen patients were included, with a mean follow‐up of 42.5 months (range: 24‐62 months). All outcome measures demonstrated statistically significant improvement: VAS scores improved from 5.9 ± 1.3 to 1.8 ± 1.4; SSV scores improved from 18.0 ± 9.1 to 61.4 ± 18.5; Constant score improved from 33.3 ± 5.3 to 65.5 ± 17.4; and ASES score improved from 38.5 ± 5.2 to 67.1 ± 17.7 (all P < .001). On the basis of the minimal clinically important difference (MCID) using a 0.5 SD distribution‐based method, clinically meaningful improvements were observed in 88.9% of patients for VAS and ASES scores, and 94.4% for Constant and SSV scores. ROM gains included forward elevation (73° to 120°), abduction (57° to 93°), and external rotation (−22° to 40°). At final follow‐up, 77.8% of patients had resumed occupational activities, and 61.1% returned to sports. Four patients (22.2%) required conversion to reverse shoulder arthroplasty. Conclusions LTT transfer using an Achilles tendon allograft following failed SCR yields significant improvements in pain relief, functional outcomes, and ROM. LTT transfer using an Achilles tendon allograft following failed SCR may offer a potential treatment option, particularly in younger, active patients who seek to preserve native shoulder anatomy and function. Level of Evidence Level IV retrospective case series.
Long-term effects of 4 years of menopausal hormone therapy on white matter integrity
Faubion, Laura L. , Tosakulwong, Nirobul, Lesnick, Timothy G. , Fought, Angela J. , Kendall‐Thomas, June, Kapoor, Ekta , Fields, Julie A. , Bailey, Kent R. , James, Taryn T. , Løbo, Rogerio A. , Pal, Lubna , Hammers, Dustin B. , Cedars, Marcelle I. , Miller, Virginia M. , Harman, S. Mitchell , Gleason, Carey E. , Kantarci, Kejal , Kantarci, Kejal , Mak, Elijah , Kara, Firat , Tosakulwong, Nirobul, Reid, Robert I. , Schwarz, Christopher G. , Manson, JoAnn E. , Hammers, Dustin B , Brinton, Eliot A. , Malek‐Ahmadi, Michael , Naftolin, Frederick , Santoro, Nanette F. , Dowling, N. Maritza

Menopause | July 22, 2025 | Volume: 32 | Issue: 9 | Pages: 818-828

10.1097/gme.0000000000002562 | PMID 40694740 Get It

Objectives: To assess the long-term effects of 4 years of menopausal hormone therapy (mHT) on the brain’s white matter architecture in women who initiated mHT within 3 years of menopause onset. Methods: The Kronos Early Estrogen Prevention Study (KEEPS) was a multicenter, double-blind, randomized, placebo-controlled 4-year mHT trial with treatment arms of oral conjugated equine estrogens (oCEE), transdermal 17β-estradiol (tE2), and placebo in recently postmenopausal women. KEEPS Continuation was an observational follow-up of KEEPS participants. White matter integrity was evaluated in KEEPS Continuation participants 10 years after KEEPS completion using white matter hyperintensity volume, diffusion magnetic resonance imaging (dMRI) techniques, and cerebral infarcts. Linear regression models were fitted for each brain region to evaluate if there were differences in white matter between KEEPS treatment arms. Results: There was no evidence to suggest the long-term effects of 4 years of mHT on brain white matter in KEEPS Continuation participants [n=266, mean age 67 (58-73)]. No differences in dMRI metrics were found in each of the treatment arms (oCEE n=70; tE2 n=79) when compared to placebo (n=94), following a false discovery rate adjustment for multiple comparisons. There were no statistically significant differences in white matter hyperintensity volume or infarct occurrence when comparing each of the treatment arms to placebo. Conclusions: We found no evidence of the long-term effect of 4-year mHT on white matter integrity when compared to placebo, consistent with emerging evidence of the safety of short-term use of mHT in recently postmenopausal women.
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm
Emiloju, Oluwadunni E. , Foster, Nathan R. , Smoot, Rory L. , Graham, Rondell P. , Pai, Rish K. , Sinicrope, Frank A. , Emiloju, Oluwadunni , Ardestani, Bahar Saberzadeh, Smoot, Rory L , Graham, Rondell P , Pai, R K , Sinicrope, Frank A , Saberzadeh-Ardestani, Bahar

JCO Clinical Cancer Informatics | July 22, 2025 | Volume: No volume available | Issue: 9 | Pages: No page available

10.1200/cci-25-00004 | PMID 40694782 Get It

PURPOSE The development of colorectal liver metastases (CRLMs) is associated with poor prognosis, and recent data suggest that metastasis to the liver is associated with resistance to immunotherapy. We characterized the microenvironment of primary colorectal carcinomas (CRCs) relative to their synchronous CRLMs using a validated segmentation algorithm (QuantCRC) that quantifies 15 distinct morphologic tumor features. MATERIALS AND METHODS Adult patients with CRC with synchronous CRLM (N = 57) at Mayo Clinic were identified from the electronic health record. Routine tumor hematoxylin and eosin sections were digitized and reviewed for quality control. QuantCRC (Aiforia, Inc) was applied to digitized images to extract 15 GI pathologist predefined morphological features. Tumor features were compared between paired primary tumors and their synchronous CRLMs using the Wilcoxon signed-rank test overall and within subgroups. Linear regression models were used to find predictors of the paired differences in the distinct tumor morphological features. RESULTS The study included 57 patients (median age 59 years [IQR, 50-73], 51% female) with CRC primary and synchronous CRLM, and among primaries, 37 (65%) were left-sided. QuantCRC identified six of 15 morphological features that differed significantly between primaries and their CRLMs. Compared with the primary, CRLM showed reduced stroma, more high-grade tumor and necrosis, higher tumor–stromal ratio (TSR; all P < .05), and a trend toward increased tumor-infiltrating lymphocyte (TIL) density ( P = .052). Synchronous CRLM from patients with left-sided primary tumors had significantly higher TSR, percent high-grade, percent necrosis, and TIL density compared with the primary (all P values ≤0.04). Among right-sided primaries, CRLM had a significantly reduced percent mature stroma ( P = .0296) and a higher percent necrosis ( P = .0027). CONCLUSION Compared with the primary, synchronous CRLMs showed a higher TSR and increased high-grade tumor and necrosis, which are features of tumor aggressiveness and a metastatic phenotype.
SGLT2 inhibitors and cardiovascular outcomes in patients with multiple myeloma and concomitant type 2 diabetes mellitus
Tan, Jia Yi , Vignarajah, Aravinthan , Yeo, Yong Hao , Chisti, Mohammad Muhsin , Hilal, Talal , Chan, Kok Hoe , Chisti, Mohammad Muhsin , Hilal, Talal , Yeo, Yong Hao , Chan, Kok Hoe

Leukemia & Lymphoma | July 22, 2025 | Volume: 66 | Issue: 12 | Pages: 2320-2323

10.1080/10428194.2025.2536681 | PMID 40694617 Get It

In Response
Bradley, A. Steven, Milam, Adam J. , Milam, Adam J , Burton, Brittany N.

Anesthesia & Analgesia | July 22, 2025 | Volume: 141 | Issue: 4 | Pages: e60-e61

10.1213/ane.0000000000007674 | PMID 40694504 Get It

Redifferentiation Therapy for RAI-Refractory Thyroid Cancer
Greca, Amanda La , Boucai, Laura , Shonka, David C. , Chintakuntlawar, Ashish V.

Clinical Thyroidology® | July 22, 2025 | Volume: 37 | Issue: 7 | Pages: 254-257

10.1089/ct.2025;37.254-257 Get It

Comparative outcomes of percutaneous coronary intervention in ST-elevation myocardial infarction: an analysis by infarct-related coronary artery
Mansoor, Taha , Parikh, Sachin , Brubaker, Austin, Gupta, Vishal, Koshy, Santhosh , Ismayl, Mahmoud , Agarwal, Siddharth , Gupta, Kartik , Brubaker, Austin, Minhas, Abdul Mannan Khan

Baylor University Medical Center Proceedings | July 22, 2025 | Volume: 38 | Issue: 5 | Pages: 787-792

10.1080/08998280.2025.2530351 | PMID 40821466 Get It

Cosmetic and Surgical Dermatology Learning Needs Identified Through Continuing Certification Program Assessments of the American Board of Dermatology
Stratman, Erik J. , Schaffer, Julie V., Miller, Stanley J., Allen, David M., Bichakjian, Christopher K. , Brewer, Jerry D., Vidimos, Allison T. , Roenigk, Randall K.

Dermatologic Surgery | July 22, 2025 | Volume: 52 | Issue: 2 | Pages: 202-204

10.1097/dss.0000000000004779 | PMID 40693657 Get It

Connecting the dots: investigating the correlation between anatomic and visual outcomes in neovascular age-related macular degeneration and retinal vascular diseases
Csaky, Karl G. , Bakri, Sophie J. , Ehlers, Justis P. , Finn, Avni Patel, Ip, Michael S. , Finn, Avni P.

Expert Review of Ophthalmology | July 22, 2025 | Volume: 20 | Issue: 5 | Pages: 267-278

10.1080/17469899.2025.2535181 Get It